LAKE ZURICH, Ill., May 20, 2025--Fresenius Kabi, an operating company of Fresenius, announced today that Epinephrine Injection, USP, is now available in the United States in 30 mg per 30 mL multi ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial. Glenmark's Epinephrine Injection USP, 10 mg/10 mL (1 mg ...

This launch of epinephrine injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial is eligible for 180 days of CGT exclusivity under section 505(j)(5)(B)(v) of the FD&C Act. According to IQVIA sales ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced Acetylcysteine Solution, USP, 10% in multiple presentations – 4 mL, 10 mL and 30 mL vials – with immediate ...

In 2012, Fresenius Kabi introduced Acetylcysteine Solution, USP, 20% concentration in 10 mL vials and in 2013 the company introduced 30 mL vials and injection versions of the product.

Injectable EPINEPHrine is still available in 1 mg/mL in 1 mL ampuls or vials, 1 mg/mL in 30 mL vials, and 1 mg/10 mL (0.1 mg/mL) emergency syringes with an intracardiac needle, but these products ...

RANCHO CUCAMONGA, Calif., April 27, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) (“Amphastar”), today announces that the U.S. Food and Drug Administration (“FDA ...

Problems can occur when users attempt to replace the 1 mg/10 mL syringes by diluting a more concentrated form of the drug from an ampul or vial. ... • Reserve current supplies of EPINEPHrine ...

MAHWAH, N.J., Feb. 27, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial. Glenmark's ...